Q Fever (Coxiella burnetii) Antibodies (IgG, IgM), with Reflex to Titers
Test Summary
Caused by infection with rickettsia agent, Coxiella burnetii, Q Fever is characterized by fever with interstitial pneumonitis. Sixty percent of infected individuals are asymptomatic while other infected individuals may die from complications.
Aliases
- N/A
Specimen Collection
Special Instructions
N/A
Preferred Specimen
1 mL serum
Minimum Volume
0.2 mL
Instructions
N/A
Patient Preparation
N/A
Storage
Plastic screw-cap vial
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
- Room temperature: 4 days
- Refrigerated: 7 days
- Frozen: 30 days
Limitations
N/A
Other Acceptable Specimens
N/A
Unacceptable Specimens
N/A
Order Code
QFEVER
EPIC (Premier) Code
LAB3871
Includes
If Q Fever IgG Phase I is Positive, then Q Fever IgG Phase I Titer will be performed at an additional charge (CPT code(s): 86638).
If Q Fever IgG Phase II is Positive, then Q Fever IgG Phase II Titer will be performed at an additional charge (CPT code(s): 86638).
If Q Fever IgM Phase I is Positive, then Q Fever IgM Phase I Titer will be performed at an additional charge (CPT code(s): 86638).
If Q Fever IgM Phase II is Positive, then Q Fever IgM Phase II Titer will be performed at an additional charge (CPT code(s): 86638).
If Q Fever IgG Phase II is Positive, then Q Fever IgG Phase II Titer will be performed at an additional charge (CPT code(s): 86638).
If Q Fever IgM Phase I is Positive, then Q Fever IgM Phase I Titer will be performed at an additional charge (CPT code(s): 86638).
If Q Fever IgM Phase II is Positive, then Q Fever IgM Phase II Titer will be performed at an additional charge (CPT code(s): 86638).
CPT Code
- 86638 (x4)
Billing Code
- 670448
CPT Statement
Methodology
Immunofluorescence Assay (IFA)
FDA Status
FDA Approved
Physician Attestation of Informed Consent
N/A
Testing Laboratory
Quest Diagnostics Nichols Institute
33608 Ortega Highway
San Juan Capistrano CA, 92675
33608 Ortega Highway
San Juan Capistrano CA, 92675
Department
Reference Testing
Reference Range
| Screen | Titer | |
| Q Fever IgG Phase I | Negative | <1:16 |
| Q Fever IgG Phase II | Negative | <1:16 |
| Q Fever IgM Phase I | Negative | <1:16 |
| Q Fever IgM Phase II | Negative | <1:16 |
Setup Schedule / Expected Turnaround Time
Tuesday - Saturday; Report available: 2 - 5 days
Specimen Collection
Special Instructions
N/A
Preferred Specimen
1 mL serum
Minimum Volume
0.2 mL
Instructions
N/A
Patient Preparation
N/A
Storage
Plastic screw-cap vial
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
- Room temperature: 4 days
- Refrigerated: 7 days
- Frozen: 30 days
Limitations
N/A
Other Acceptable Specimens
N/A
Unacceptable Specimens
N/A
Result Information
Methodology
Immunofluorescence Assay (IFA)
Testing Laboratory
N/A
Reference Range
| Screen | Titer | |
| Q Fever IgG Phase I | Negative | <1:16 |
| Q Fever IgG Phase II | Negative | <1:16 |
| Q Fever IgM Phase I | Negative | <1:16 |
| Q Fever IgM Phase II | Negative | <1:16 |
Setup Schedule / Expected Turnaround Time
Tuesday - Saturday; Report available: 2 - 5 days